Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$44.2 - $50.2 $2.26 Million - $2.57 Million
51,187 Added 102.85%
100,957 $4.6 Million
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $154,106 - $325,336
-4,837 Reduced 8.86%
49,770 $2.16 Million
Q1 2023

May 15, 2023

SELL
$45.44 - $74.26 $1.53 Million - $2.49 Million
-33,591 Reduced 38.09%
54,607 $3.59 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $2.08 Million - $4.06 Million
50,138 Added 131.73%
88,198 $3.97 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $2.03 Million - $3.17 Million
28,072 Added 281.06%
38,060 $2.75 Million
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $258,373 - $337,930
-2,963 Reduced 22.88%
9,988 $1.07 Million
Q1 2022

May 16, 2022

SELL
$94.19 - $124.49 $21,569 - $28,508
-229 Reduced 1.74%
12,951 $1.44 Million
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $6,695 - $7,787
-56 Reduced 0.42%
13,180 $1.69 Million
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $88,318 - $115,161
809 Added 6.51%
13,236 $1.76 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $44,550 - $51,366
444 Added 3.71%
12,427 $1.34 Million
Q1 2021

May 14, 2021

SELL
$101.51 - $125.27 $14,718 - $18,164
-145 Reduced 1.2%
11,983 $1.26 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $740,285 - $908,203
8,620 Added 245.72%
12,128 $1.26 Million
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $255,171 - $324,490
3,508 New
3,508 $300,000
Q4 2017

Feb 14, 2018

SELL
$37.27 - $43.02 $465,875 - $537,750
-12,500 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$33.75 - $41.67 $421,875 - $520,875
12,500
12,500 $499,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.